At a glance
ClinicalIndex Comparison RecordN/ACompleted· 830 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment-Resistant Depression Cohort in Europe
In Brief
An observational study for Depressive Disorder, Treatment-Resistant. Completed, enrolled 830 participants across 98 sites in 7 countries.
Detailed Summary
The purpose of this study is to assess the participants socio-demographics and disease-related characteristics, long-term naturalistic treatment patterns and the clinical, social and economic outcomes of routine clinical practice in the treatment of participants with treatment-resistant depression (TRD) in a variety of European countries.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDepressive Disorder, Treatment-Resistant
CountriesBelgium, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 2017
Enrollment StartFeb 2018
Primary CompletionJan 2020
TodayJul 2026
First PostedDec 14, 2017
Enrollment StartFeb 13, 2018
Primary CompletionJan 24, 2020
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.5 years ago